In connection with the acquisition of Corvette Pharmaceutical Services Group completed on October 1, 2014, Recipharm AB (publ) (“Recipharm”) issued convertible bonds with a nominal value of EUR 50 million as part of the financing of the acquisition. The convertible bonds can be converted into up to 5,030,549 class B-shares. The holders of the convertible bonds have agreed to a lock-up in respect of the new shares issued upon conversion until 14 February, 2015. Recipharm has received a request and has released the lock-up on 815,000 B -shares related to shares to be issued upon conversion of the convertible bonds. The release of the lock-up has been granted to facilitate the sale of 815,000 class B-shares to three Swedish and Finnish long-only fund managers. Together with yesterdays transaction Recipharm has released the lock-up on 2 115 000 class B-shares out of the total 5,030,549 mentioned above. For further information please visit www.recipharm.com or contact: Thomas Eldered, CEO, thomas.eldered@recipharm.com, telephone: +46 8 602 52 00 Björn Westberg, CFO, bjorn.westberg@recipharm.com, telephone: +46 8 602 46 20 This information is published in accordance with the Swedish Securities Market Act, the Swedish Financial Instruments Trading Act and/or the regulations of NASDAQ Stockholm. This information was submitted for publication on 22nd January 2015 at 13:45 CET. About Recipharm Recipharm is a leading CDMO (Contract Development and Manufacturing Organisation) in the pharmaceutical industry based in Sweden employing some 2,200 employees. Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material including API and pharmaceutical product development. Recipharm manufactures more than 400 different products to customers ranging from Big Pharma through to smaller research and development companies. Recipharm’s turnover is approximately SEK 3.3 billion and the Company operates development and manufacturing facilities in Sweden, France, the UK, Germany, Spain, Italy and Portugal and is headquartered in Jordbro, Sweden. The Recipharm B-share (RECI B) is listed on NASDAQ Stockholm. For more information on Recipharm and our services, please visit www.recipharm.com (http://file///C:/Users/Thomas/AppData/Local/Microsoft/Windows / Temporary%20Internet%20Files/Content.Outlook/FZHEQOEB/visit%20www.recipharm.com) . Recipharm AB (publ) Corporate identity number 556498-8425 Address Lagervägen 7, SE-136 50 Jordbro, Sweden, Telephone 46 8 602 52 00, Fax 46 8 81 87 03 www.recipharm.com
Recipharm releases the lock-up on 815,000 B-shares related
Top 10 Most Recent News Articles
YSTUDIO's Pens: A Nod to the Power of Writing
Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...
Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward
Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...
Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG
New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...
Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched
Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...
Continue Reading
Novo's Research Unlocks New Insights into Food Noise
Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....
Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms
Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...
Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results
Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...
Continue Reading
Webull Faces Class Action: Key Details for Investors
What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...
Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims
AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...
Continue Reading
BETR's Slide: Investors Face Big Losses, Leadership Shift
BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...
Continue ReadingTop 5 Most Recently Viewed Articles
Turkish Stock Market Faces Decline Amid Sector Losses
Turkish Stock Performance Overview The stock market in Turkey experienced a noticeable decline recently, driven primarily by losses in critical sectors such as Banking, Food & Beverages, and Basic Metals. These losses have contributed to an overall decrease in stock values, painting a challenging picture for investors. BIST 100 Index Decline At the close of trading, the...
Continue Reading
TaxDome Achieves Recognition in CPA Practice Advisor Awards
TaxDome Triumphs in CPA Practice Advisor Efforts TaxDome, a leading practice management solution specially designed for tax professionals and accounting firms, has received outstanding recognition in the 2025 CPA Practice Advisor Readers' Choice Awards. Winning seven accolades and securing two runner-up positions, this achievement underscores the trust and esteem that the...
Continue Reading
Citi's Positive Outlook for Grab Holdings: A Buy Recommendation
Citi Reaffirms Buy Rating on Grab Holdings Inc. In a recent note, Citi has reinforced its Buy rating on Grab Holdings Inc. (NASDAQ:GRAB), maintaining a price objective of $5.00. Analysts at Citi anticipate that Grab will announce its third-quarter results around mid-November. The firm prepared adjustments to International Financial Reporting Standards (IFRS) revenue and...
Continue Reading
Exploring Unusual Options Activity for American Airlines Group
Insights into American Airlines Group's Options Activity In the bustling world of finance, American Airlines Group (NASDAQ: AAL) has drawn attention due to a notable surge in bullish options trading. Recently, our in-depth analysis unveiled a series of unusual trades that are shaping investor sentiment around American Airlines Group. Understanding the Options Activity The...
Continue Reading
CTERA Revolutionizes Hybrid Cloud Storage with MCP Support
CTERA Leads the Way in Hybrid Cloud Innovations CTERA, the frontrunner in Enterprise Data Services, has recently announced an exciting advancement that positions it as a pioneer in hybrid cloud storage: the native support for the Model Context Protocol (MCP). This integration allows the hybrid cloud platform to embed an MCP Server, facilitating secure connections to...
Continue Reading